Equity Details
Price & Market Data
Price: $0.0899
Daily Change: +$0.0187 / 20.75%
Daily Range: $0.0713 - $0.09
Market Cap: $2,617,826
Daily Volume: 75,360
Performance Metrics
1 Week: 23.53%
1 Month: 40.60%
3 Months: 116.2%
6 Months: -6.98%
1 Year: -46.67%
YTD: 58.42%
About Hepion Pharmaceuticals, Inc. (HEPA)
Uncover the latest on Hepion Pharmaceuticals, Inc. (HEPA). Trading at 0.0899, the stock has shown a daily change of +$0.0187 / 20.75%. With a market cap of 2,617,826, its performance over the last week (23.53%) and month (40.60%) provides key insights.
Company Details
Employees: 2
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatment for hepatocellular carcinoma (HCC), metabolic liver diseases, and chronic liver diseases in the United States. It developed Rencofilstat, a therapeutic drug candidate that binds and inhibits the function of a specific class of isomerase enzymes called cyclophilins that regulates protein folding, as well as preclinical experiments of Rencofilstat reflects decreased liver fibrosis; liver inflammation; liver tumor burden; and titers of HBV, HCV, and HDV. The company was formerly known as ContraVir Pharmaceuticals, Inc. and changed its name to Hepion Pharmaceuticals, Inc. in July 2019. Hepion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Morristown, New Jersey.